Skip to search formSkip to main contentSkip to account menu

Ergot preparation

Known as: ERGOT, ergots 
National Institutes of Health

Related topics

Related topics

12 relations
AmprenavirAngina Pectoris, VariantCerebral Arterial Vasoconstriction [PE]Drug Allergy

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Laboratory, Greenhouse, and Field Assessment of Fourteen Fungicides for Activity Against Claviceps africana, Causal Agent of Sorghum Ergot.
Commercial formulations of 14 fungicides representing seven chemical classes were assessed in vitro and in vivo for activity… 
1998
1998
Putative Perception of Rotating Permanent Magnetic Fields following Ingestion of LSD
While sitting alone in complete darkness, 3 participants who had ingested psychotropic concentrations of lysergic acid… 
1980
1980
REVERSAL OF ERGOTAMINE-INDUCED ARTERIOSPASM BY MECHANICAL INTRA-ARTERIAL DILATATION
1979
1979
CARDIOVASCULAR EFFECTS OF ERGOT DERIVATIVES IN MAN
1975
1975
Ergot-induced vasospasm of the lower extremities treated with epidural anaesthesia.
No reliable treatment to reverse severe ergot-induced vasopasm is available. A case of ergotamine-induced vasospasm of the lower… 
1939
1939
UNTOWARD EFFECTS FROM THE USE OF ERGOT AND ERGOTAMINE TARTRATE
Excerpt Ergot preparations have enjoyed a time-honored place in obstetrical practice. In properly standardized dosage they have… 
1936
1936
A method for the prognosis of the development of ergot (Claviceps purpurea Tul.).
1935
1935
THE NEW ACTIVE PRINCIPLE OF ERGOT.
1935
1935
THE NEW ACTIVE PRINCIPLE OF ERGOT.
1935
1935
THE NEW ACTIVE PRINCIPLE(S) OF ERGOT.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)